Paras Healthcare Shares Make Tepid Debut, Stock Lists With Nearly 4% Premium

Shares of Paras Healthcare made their debut in the stock market on October 28, 2026, with a premium of nearly 4 per cent over the upper end of the price band. On the BSE and NSE the shares were listed at Rs 720 per share, with a premium of 3.89 per cent above the upper end of the price band of Rs 693.

Paras Healthcare IPO: Listing Day Profit

Applicants who were successfully allotted a minimum of one lot or 21 shares of Paras Healthcare would have made a profit of around Rs 567 [(Rs 720- Rs 693) x 21] after the stock listed on the exchanges. The company’s market capitalisation stood at Rs 1,595.48 crore after listing, and 77,000 shares of the company changed hands.

Paras Healthcare IPO: Offer Size

The initial public offering (IPO) of Paras Healthcare was a book-built issue worth Rs 1,450 crore and consisted of a fresh issue of 7.21 million shares worth Rs 500 crore and an offer for sale (OFS) of 13.70 million shares amounting to Rs 950 crore. The price band for the public issue was fixed at Rs 660-693 per share. The minimum lot size for retail investors was fixed at 21 shares, aggregating to an investment of Rs 14,553.

Paras Healthcare IPO: Subscription

The IPO saw decent demand and was oversubscribed 2.23 times during its subscription period from October 21 to October 23. Investors across categories placed bids for 26.94 million shares compared to the total offer size of 12.08 million shares available.

Non-institutional investors (NIIs) booked their quota in the IPO 66 per cent. In this category, 3.29 million shares were offered, and bids were received for 2.16 million shares.

Retail investors booked their quota 2 times, bidding for 4.39 million shares against the 2.19 million shares offered. The qualified institutional buyer (QIB) quota was subscribed 3.09 times, receiving bids for 20.38 million shares against the 6.59 million shares offered.

Paras Healthcare: Promoters

The promoter of the company, Dharminder Kumar Nagar, diluted a portion of his stakes through the OFS. Following the listing of the stock, the promoter and promoter group shareholding reduced to 63.95 per cent, down from 72.80 per cent prior to the public issue.

Paras Healthcare: Competitors

Paras Healthcare operates within the clinical specialty-led hospital sector, providing tertiary and quaternary healthcare services across North India, Bihar, and Jharkhand. The company’s listed peers in the domestic market include Rays of Belief, Manipal Health Enterprises, Gujarat Kidney & Super Speciality, Park Medi World, ABH Healthcare and Hannah Joseph Hospital.

Paras Healthcare IPO: Objective

The company will use the proceeds from the fresh issue for prepayment or scheduled repayment, in full or part, of certain outstanding borrowings, investment in its wholly owned subsidiary (PMHPL) for the repayment/prepayment of borrowings, and will allocate the remaining proceeds for general corporate purposes.